Large-scale testing (Phase 3)Study completedNCT04622046
What this trial is testing
ALXN2060 in Japanese Participants With Symptomatic ATTR-CM
Who this might be right for
Symptomatic Transthyretin Amyloid Cardiomyopathy
Alexion Pharmaceuticals, Inc. 25